rs45438898

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000548.5(TSC2):​c.4269G>A​(p.Leu1423Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,609,194 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1423L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0036 ( 25 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:27O:1

Conservation

PhyloP100: -0.290

Publications

10 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-2084491-G-A is Benign according to our data. Variant chr16-2084491-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 49289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00284 (433/152352) while in subpopulation NFE AF = 0.00375 (255/68020). AF 95% confidence interval is 0.00337. There are 1 homozygotes in GnomAd4. There are 211 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 433 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.4269G>Ap.Leu1423Leu
synonymous
Exon 34 of 42NP_000539.2P49815-1
TSC2
NM_001406663.1
c.4266G>Ap.Leu1422Leu
synonymous
Exon 34 of 42NP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.4200G>Ap.Leu1400Leu
synonymous
Exon 33 of 41NP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.4269G>Ap.Leu1423Leu
synonymous
Exon 34 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.4200G>Ap.Leu1400Leu
synonymous
Exon 33 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.4068G>Ap.Leu1356Leu
synonymous
Exon 32 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.00284
AC:
433
AN:
152234
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.0758
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00470
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00375
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00264
AC:
630
AN:
238522
AF XY:
0.00292
show subpopulations
Gnomad AFR exome
AF:
0.000540
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00513
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00350
Gnomad NFE exome
AF:
0.00357
Gnomad OTH exome
AF:
0.00292
GnomAD4 exome
AF:
0.00361
AC:
5252
AN:
1456842
Hom.:
25
Cov.:
33
AF XY:
0.00365
AC XY:
2648
AN XY:
724646
show subpopulations
African (AFR)
AF:
0.000569
AC:
19
AN:
33372
American (AMR)
AF:
0.00120
AC:
53
AN:
44300
Ashkenazi Jewish (ASJ)
AF:
0.00453
AC:
118
AN:
26024
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39504
South Asian (SAS)
AF:
0.00225
AC:
193
AN:
85716
European-Finnish (FIN)
AF:
0.00354
AC:
182
AN:
51358
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5762
European-Non Finnish (NFE)
AF:
0.00405
AC:
4501
AN:
1110620
Other (OTH)
AF:
0.00291
AC:
175
AN:
60186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
426
852
1279
1705
2131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00284
AC:
433
AN:
152352
Hom.:
1
Cov.:
34
AF XY:
0.00283
AC XY:
211
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41588
American (AMR)
AF:
0.000588
AC:
9
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4826
European-Finnish (FIN)
AF:
0.00470
AC:
50
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00375
AC:
255
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00372
Hom.:
0
Bravo
AF:
0.00275
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not provided (8)
-
-
7
not specified (7)
-
-
6
Tuberous sclerosis 2 (6)
-
-
3
Tuberous sclerosis syndrome (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.72
DANN
Benign
0.75
PhyloP100
-0.29
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45438898; hg19: chr16-2134492; COSMIC: COSV104375925; API